Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth
Fatty acid synthase (FASN) is the terminal enzyme in de novo lipogenesis and plays a key role in cell proliferation. Pharmacologic inhibitors of FASN are being evaluated in clinical trials for treatment of cancer, obesity, and other diseases. Here, we report a previously unknown mechanism of FASN re...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 76; no. 23; pp. 6924 - 6936 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.12.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!